BIOMAT Database Logo BIOMAT Database Logo

Second-generation leukotriene B4 receptor antagonists related to SC-41930: heterocyclic replacement of the methyl ketone pharmacophore. 1995

T D Penning, and S W Djuric, and J M Miyashiro, and S Yu, and J P Snyder, and D Spangler, and C P Anglin, and D J Fretland, and J F Kachur, and R H Keith
Department of Chemistry, Searle Research and Development, Skokie, Illinois 60077.

Our previous reports have highlighted the first-generation leukotriene B4 (LTB4) receptor antagonist SC-41930 (7-[3-(4-acetyl-3-methoxy-2-propylphenoxy)propoxy]3,4- dihydro-8-propyl-2H-1-benzopyran-2-carboxylic acid) which has potent oral, topical, and intracolonic activity in various animal models of inflammation. Extensive structure-activity relationship studies, in which a series of heterocyclic replacements for the methyl ketone functional group of SC-41930 was explored, identified SC-50605 (7-[3-[2-(cyclopropylmethyl)-3-methoxy-4- (4-thiazolyl)phenoxy]propoxy]-3,4-dihydro-8-propyl-2H-1-benzopyran-2- carboxylic acid) as an optimized analog within a series of thiazoles. SC-50605 was found to be significantly more potent than SC-41930 in LTB4 receptor binding, chemotaxis, and degranulation assays. It also displayed very good activity in animal models of colitis and epidermal inflammation by oral, topical, intravenous, and intracolonic routes of administration. The resolved enantiomers of SC-50605 were obtained by chiral chromatography and both demonstrated good in vitro and in vivo activity. The (+)-isomer (SC-52798) is currently being evaluated as a potential clinical candidate for psoriasis and ulcerative colitis therapy.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009240 N-Formylmethionine Leucyl-Phenylalanine A formylated tripeptide originally isolated from bacterial filtrates that is positively chemotactic to polymorphonuclear leucocytes, and causes them to release lysosomal enzymes and become metabolically activated. F-Met-Leu-Phe,N-Formyl-Methionyl-Leucyl-Phenylalanine,Formylmet-Leu-Phe,Formylmethionyl Peptide,Formylmethionyl-Leucyl-Phenylalanine,Formylmethionylleucylphenylalanine,N-Formylated Peptide,N-formylmethionyl-leucyl-phenylalanine,fMet-Leu-Phe,F Met Leu Phe,Formylmet Leu Phe,Formylmethionyl Leucyl Phenylalanine,Leucyl-Phenylalanine, N-Formylmethionine,N Formyl Methionyl Leucyl Phenylalanine,N Formylated Peptide,N Formylmethionine Leucyl Phenylalanine,N formylmethionyl leucyl phenylalanine,Peptide, Formylmethionyl,Peptide, N-Formylated,fMet Leu Phe
D002630 Chemotactic Factors Chemical substances that attract or repel cells. The concept denotes especially those factors released as a result of tissue injury, microbial invasion, or immunologic activity, that attract LEUKOCYTES; MACROPHAGES; or other cells to the site of infection or insult. Chemoattractant,Chemotactic Factor,Chemotaxin,Chemotaxins,Cytotaxinogens,Cytotaxins,Macrophage Chemotactic Factor,Chemoattractants,Chemotactic Factors, Macrophage,Macrophage Chemotactic Factors,Chemotactic Factor, Macrophage,Factor, Chemotactic,Factor, Macrophage Chemotactic
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001393 Azoles Five membered rings containing a NITROGEN atom. Azole
D001578 Benzopyrans Compounds with a core of fused benzo-pyran rings. Benzopyran,Chromene,Chromenes
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

T D Penning, and S W Djuric, and J M Miyashiro, and S Yu, and J P Snyder, and D Spangler, and C P Anglin, and D J Fretland, and J F Kachur, and R H Keith
Multiple actions of the leukotriene B4 receptor antagonist SC-41930.
January 1992, The Journal of pharmacology and experimental therapeutics,
T D Penning, and S W Djuric, and J M Miyashiro, and S Yu, and J P Snyder, and D Spangler, and C P Anglin, and D J Fretland, and J F Kachur, and R H Keith
Inflammation of guinea pig dermis. Effects of leukotriene B4 receptor antagonist, SC-41930.
December 1990, Inflammation,
T D Penning, and S W Djuric, and J M Miyashiro, and S Yu, and J P Snyder, and D Spangler, and C P Anglin, and D J Fretland, and J F Kachur, and R H Keith
SC-41930: an inhibitor of leukotriene B4-stimulated human neutrophil functions.
December 1989, Prostaglandins,
T D Penning, and S W Djuric, and J M Miyashiro, and S Yu, and J P Snyder, and D Spangler, and C P Anglin, and D J Fretland, and J F Kachur, and R H Keith
The effect of leukotriene-B4 receptor antagonist, SC-41930, on acetic acid-induced colonic inflammation.
June 1989, Agents and actions,
T D Penning, and S W Djuric, and J M Miyashiro, and S Yu, and J P Snyder, and D Spangler, and C P Anglin, and D J Fretland, and J F Kachur, and R H Keith
Effects of two leukotriene B4 (LTB4) receptor antagonists (LY255283 and SC-41930) on LTB4-induced human neutrophil adhesion and superoxide production.
August 1991, Prostaglandins, leukotrienes, and essential fatty acids,
T D Penning, and S W Djuric, and J M Miyashiro, and S Yu, and J P Snyder, and D Spangler, and C P Anglin, and D J Fretland, and J F Kachur, and R H Keith
Effect of the leukotriene B4 receptor antagonist, SC-41930, on experimental allergic encephalomyelitis (EAE) in the guinea pig.
September 1991, Agents and actions,
T D Penning, and S W Djuric, and J M Miyashiro, and S Yu, and J P Snyder, and D Spangler, and C P Anglin, and D J Fretland, and J F Kachur, and R H Keith
Effect of the leukotriene B4 receptor antagonist SC-41930 on colonic inflammation in rat, guinea pig and rabbit.
November 1990, The Journal of pharmacology and experimental therapeutics,
T D Penning, and S W Djuric, and J M Miyashiro, and S Yu, and J P Snyder, and D Spangler, and C P Anglin, and D J Fretland, and J F Kachur, and R H Keith
SC-41930, a leukotriene B4 receptor antagonist, inhibits 12(S)-hydroxyeicosatetraenoic acid (12(S)-HETE) binding to epidermal cells.
March 1991, Agents and actions,
T D Penning, and S W Djuric, and J M Miyashiro, and S Yu, and J P Snyder, and D Spangler, and C P Anglin, and D J Fretland, and J F Kachur, and R H Keith
Flow cytometric evaluation of the effects of leukotriene B4 receptor antagonists (LY255283 and SC-41930) on calcium mobilization and integrin expression of activated human neutrophils.
August 1992, Prostaglandins, leukotrienes, and essential fatty acids,
T D Penning, and S W Djuric, and J M Miyashiro, and S Yu, and J P Snyder, and D Spangler, and C P Anglin, and D J Fretland, and J F Kachur, and R H Keith
Effect of SC-41930, a potent selective leukotriene B4 receptor antagonist, in the guinea pig model of middle ear inflammation.
June 1996, The Annals of otology, rhinology, and laryngology,
Copied contents to your clipboard!